Joseph M. Obeid

597 total citations
13 papers, 371 citations indexed

About

Joseph M. Obeid is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Joseph M. Obeid has authored 13 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 4 papers in Surgery. Recurrent topics in Joseph M. Obeid's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Joseph M. Obeid is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Joseph M. Obeid collaborates with scholars based in United States, Qatar and Switzerland. Joseph M. Obeid's co-authors include Craig L. Slingluff, Donna H. Deacon, Yinin Hu, Gulsun Erdag, Timothy N. J. Bullock, Mark E. Smolkin, James W. Patterson, Mouadh Benamar, Tarek Abbas and Fadila Guessous and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Immunology Immunotherapy and EBioMedicine.

In The Last Decade

Joseph M. Obeid

12 papers receiving 367 citations

Peers

Countries citing papers authored by Joseph M. Obeid

Since Specialization

Citations

This map shows the geographic impact of Joseph M. Obeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M. Obeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M. Obeid more than expected).

Fields of papers citing papers by Joseph M. Obeid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M. Obeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M. Obeid. The network helps show where Joseph M. Obeid may publish in the future.

Co-authorship network of co-authors of Joseph M. Obeid

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph M. Obeid. A scholar is included among the top collaborators of Joseph M. Obeid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph M. Obeid. Joseph M. Obeid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Joseph M. Obeid, Ileana S. Mauldin, (unknown), (unknown), (unknown), (unknown), Ryan D. Gentzler, Nolan A. Wages, Craig L. Slingluff, Timothy N. J. Bullock, Sepideh Dolatshahi, Michael G. Brown	3
2	Atrial fibrillation in mechanical circulatory support patients 2022 ·Vessel Plus ·Joseph M. Obeid, (unknown), Allison J. McLarty, Henry Tannous, Thomas V. Bilfinger, A. Laurie Shroyer	0
3	Myeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor Location 2021 ·Journal of Immunotherapy ·Paul R. Kunk, Sean C. Dougherty, Kevin Lynch, (unknown), Max O. Meneveau, Joseph M. Obeid, (unknown), (unknown), Edward B. Stelow, Todd W. Bauer, Craig L. Slingluff, Osama E. Rahma	7
4	Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma 2019 ·OncoImmunology ·Katie M. Leick, Joseph M. Obeid, Stefan Bekiranov, Craig L. Slingluff	7
5	Mismatch repair deficiency in cholangiocarcinoma. 2018 ·Journal of Clinical Oncology ·Paul R. Kunk, Joseph M. Obeid, (unknown), Patcharin Pramoonjago, Dirk G. Brockstedt, Anita Giobbie‐Hurder, Edward B. Stelow, Todd W. Bauer, Craig L. Slingluff, Osama E. Rahma	8
6	Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time? 2017 ·Cancer Immunology Immunotherapy ·Joseph M. Obeid, Paul R. Kunk, Victor M. Zaydfudim, Timothy N. J. Bullock, Craig L. Slingluff, Osama E. Rahma	20
7	The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity? 2017 ·Melanoma Research ·Joseph M. Obeid, Yinin Hu, Gulsun Erdag, Katie M. Leick, Craig L. Slingluff	18
8	Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies 2016 ·Cancer Immunology Immunotherapy ·Joseph M. Obeid, Nolan A. Wages, Yinin Hu, Donna H. Deacon, Craig L. Slingluff	33
9	Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk 2016 ·OncoImmunology ·(unknown), Davide Bedognetti, Ileana S. Mauldin, Donna H. Deacon, Sofia M. Shea, Joel Pinczewski, Joseph M. Obeid, George Coukos, Ena Wang, Thomas F. Gajewski, Francesco M. Marincola, Craig L. Slingluff	51
10	PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome 2016 ·OncoImmunology ·Joseph M. Obeid, Gulsun Erdag, Mark E. Smolkin, Donna H. Deacon, James W. Patterson, (unknown), Timothy N. J. Bullock, Craig L. Slingluff	103
11	Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma 2016 ·EBioMedicine ·Mouadh Benamar, Fadila Guessous, (unknown), (unknown), Joseph M. Obeid, Daniel Gioeli, Craig L. Slingluff, Tarek Abbas	58
12	Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis 2016 ·Annals of Transplantation ·Kazuhiro Takahashi, Joseph M. Obeid, Charlotte Burmeister, Bruno David, Marwan Kazimi, Atsushi Yoshida, Marwan Abouljoud, Gabriel T. Schnickel	32
13	Vaccines, Adjuvants, and Dendritic Cell Activators—Current Status and Future Challenges 2015 ·Seminars in Oncology ·Joseph M. Obeid, Yinin Hu, Craig L. Slingluff	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact